Avapro Tablet, Film Coated
Product Images NDC 0024-5851

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Avapro (NDC 0024-5851). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sanofi-aventis U.s. Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Avapro 01)

Chemical structure diagram of irbesartan, the active ingredient in Avapro tablets. The structure includes a bicyclic ring and multiple functional groups typical for this angiotensin receptor blocker.*

FDA Label Image

Figure 1 (Avapro 02)

A scatter plot graph depicting the relationship between irbesartan dose (mg/day) on the x-axis and placebo-subtracted reduction in trough SeSBP (mmHg) on the y-axis, showing an integrated analysis. Data points trend upwards and plateau around 10 mmHg as dose increases up to 900 mg/day.*

FDA Label Image

Figure 2 (Avapro 03)

A dose-response curve chart showing the placebo-subtracted reduction in trough SeDBP (systolic diastolic blood pressure) as a function of irbesartan dose in mg/day. The x-axis represents the irbesartan dose from 0 to 900 mg/day, and the y-axis shows the reduction in mmHg, ranging approximately from -2 to 8 mmHg. Data points and a fitted curve indicate the relationship.*

FDA Label Image

Figure 3 (Avapro 04)

A Kaplan-Meier cumulative event rate graph comparing Avapro, Amlodipine, and Placebo over 60 months of follow-up. The x-axis represents months of follow-up, and the y-axis shows cumulative event rate percentage. The graph includes relative risk (RR) and p-values comparing Avapro versus Placebo and Avapro versus Amlodipine.*

FDA Label Image

Principal Display Panel (75 mg Tablet Bottle Label)

Avapro 75 mg film-coated tablets packaging label showing the proprietary name Avapro and generic name irbesartan. The label indicates each tablet contains 75 mg of irbesartan. It displays the package size of 90 tablets, is marked Rx only, and is labeled by Sanofi-Aventis U.S. LLC. Additional details include storage instructions and a barcode.*

FDA Label Image

Principal Display Panel (150 mg Tablet Bottle Label)

The packaging label for Avapro (irbesartan) Tablets 150 mg displays a carton panel with 30 tablets. The label includes the proprietary and generic names, strength, NDC 0024-5851-30, and states 'Rx only.' It lists storage instructions and the labeler as Sanofi-Aventis U.S. LLC. Barcode and lot/expiration placeholders are also present.*

FDA Label Image

Principal Display Panel (300 mg Tablet Bottle Label)

Avapro (irbesartan) Tablets 300 mg film-coated, oral dosage form. The label indicates a bottle containing 30 tablets. Manufactured or labeled by Sanofi-Aventis U.S. LLC. The label includes product information, barcode, and lot and expiration date fields.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.